Our laboratory revealed that suppression of NRIP1 in CD4+ T cells that were isolated from psoriasis patients could downregulate the expression of RelA/p65 and decrease the secretion of IL-17, thus inhibiting the inflammation in psoriasis (141). This evidence concerns the gene CD4 and psoriasis.